Effect of rituximab combined with CVAD regimen on serum VEGF and β 2 -MG levels in patients with primary gastrointestinal B-cell lymphoma

por Shi-Tong Zhang, Ai-Min Wang, Zhi-Hui Sun, Jing-Jing Song, Xiao-Yu Xuan, Wei Liu, Xin-Chun Tian
Publicado em 2019-12-01